The central role of thrombin in bleeding disorders.
暂无分享,去创建一个
[1] C. Négrier,et al. Emicizumab should be prescribed independent of immune tolerance induction. , 2018, Blood advances.
[2] J. Heemskerk,et al. Integrating platelet and coagulation activation in fibrin clot formation , 2018, Research and practice in thrombosis and haemostasis.
[3] A. Lienhart,et al. Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab , 2018, Haematologica.
[4] E K Waters,et al. Concizumab, an anti‐tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[5] H. Hemker,et al. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH , 2017, Journal of thrombosis and haemostasis : JTH.
[6] J. Oldenburg,et al. Emicizumab Prophylaxis in Hemophilia A with Inhibitors , 2017, The New England journal of medicine.
[7] A. Akinc,et al. Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy , 2017, The New England journal of medicine.
[8] J. Burthem,et al. Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] J. Huntington,et al. Design and characterization of an APC-specific serpin for the treatment of hemophilia. , 2017, Blood.
[10] Flora Peyvandi,et al. The past and future of haemophilia: diagnosis, treatments, and its complications , 2016, The Lancet.
[11] Tetsuji Sato,et al. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A. , 2016, The New England journal of medicine.
[12] J. Oldenburg,et al. A critical appraisal of one‐stage and chromogenic assays of factor VIII activity , 2016, Journal of thrombosis and haemostasis : JTH.
[13] R. Montgomery,et al. Comparison of platelet‐derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay , 2015, Journal of thrombosis and haemostasis : JTH.
[14] S. Lethagen,et al. Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial , 2015, Journal of thrombosis and haemostasis : JTH.
[15] S. Milstein,et al. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia , 2015, Nature Medicine.
[16] H. Brinkman. Global assays and the management of oral anticoagulation , 2015, Thrombosis Journal.
[17] A. Hillarp,et al. One‐stage vs. chromogenic assays in haemophilia A , 2015, European journal of haematology.
[18] M. Lancé. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis , 2015, Thrombosis Journal.
[19] M. Karimi,et al. Evaluation of Thrombin Generation Assay in Patients With Hemophilia , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[20] V. Laux,et al. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94‐9027) for haemophilia A , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.
[21] K. Brummel-Ziedins,et al. Developing individualized coagulation profiling of disease risk: thrombin generation dynamic models of the pro and anticoagulant balance. , 2014, Thrombosis research.
[22] H. Mani,et al. Main considerable factors for correct laboratory test interpretation under DOA treatment , 2013, Thrombosis Journal.
[23] J. Thachil,et al. Towards standardization of clot waveform analysis and recommendations for its clinical applications , 2013, Journal of thrombosis and haemostasis : JTH.
[24] S. Krishnaswamy. The transition of prothrombin to thrombin , 2013, Journal of thrombosis and haemostasis : JTH.
[25] T. Orfeo,et al. From Principle to Practice: Bridging the Gap in Patient Profiling , 2013, PloS one.
[26] R. van Oerle,et al. Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method , 2012, Journal of thrombosis and haemostasis : JTH.
[27] T. Orfeo,et al. Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. , 2012, Thrombosis research.
[28] K. Mann,et al. Is there value in kinetic modeling of thrombin generation? Yes , 2012, Journal of thrombosis and haemostasis : JTH.
[29] Y. Dargaud,et al. Mechanisms and monitoring of bypassing agent therapy , 2012, Journal of thrombosis and haemostasis : JTH.
[30] G. Barillari,et al. Whole blood rotation thromboelastometry (ROTEM®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[31] M. Feuring,et al. Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[32] C. Danforth,et al. Defining the Boundaries of Normal Thrombin Generation: Investigations into Hemostasis , 2012, PloS one.
[33] K. Mann. Thrombin generation in hemorrhage control and vascular occlusion. , 2011, Circulation.
[34] R. Schaub,et al. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. , 2011, Blood.
[35] M. Makris,et al. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies , 2011, International journal of laboratory hematology.
[36] A. Lienhart,et al. Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. , 2010, Blood.
[37] C. Ruan,et al. Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[38] S. Nair,et al. Tests of global haemostasis and their applications in bleeding disorders , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[39] A. Wolberg,et al. Plasma and cellular contributions to fibrin network formation, structure and stability , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[40] J. Astermark,et al. Thrombin generation in vitro in the presence of by‐passing agents in siblings with severe haemophilia A , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[41] K. Mann,et al. Thrombin generation and bleeding in haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.
[42] Kenichi A Tanaka,et al. Blood Coagulation: Hemostasis and Thrombin Regulation , 2009, Anesthesia and analgesia.
[43] J. Thachil,et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation , 2009, British journal of haematology.
[44] G. Lippi,et al. Thrombin generation assay: a useful routine check‐up tool in the management of patients with haemophilia? , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.
[45] S. Moll,et al. Inherited antithrombin deficiency: a review , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[46] E. Berntorp,et al. Standardization and clinical utility of thrombin-generation assays. , 2008, Seminars in thrombosis and hemostasis.
[47] M. Prins,et al. Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory , 2008, Thrombosis and Haemostasis.
[48] W. V. van Heerde,et al. Diagnosis of factor VIII deficiency , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[49] Tomoko Matsumoto,et al. New assays for monitoring haemophilia treatment , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[50] C. Négrier,et al. Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[51] A. Srivastava,et al. The phenotypic heterogeneity of severe hemophilia. , 2008, Seminars in thrombosis and hemostasis.
[52] Alisa S Wolberg,et al. Thrombin generation, fibrin clot formation and hemostasis. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[53] S. Béguin,et al. Thrombin-generating capacity in patients with von Willebrand’s disease , 2007, Haematologica.
[54] H. Alexander,et al. The impact of major surgery on blood coagulation factors and thrombin generation , 2007, American journal of hematology.
[55] D. Lane,et al. The central role of thrombin in hemostasis , 2007, Journal of thrombosis and haemostasis : JTH.
[56] G. Young,et al. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[57] A. Giles,et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay , 2006, Journal of thrombosis and haemostasis : JTH.
[58] F. Depasse,et al. Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay , 2005, Thrombosis journal.
[59] J. Ingerslev,et al. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one‐stage clotting assays , 2004, Journal of thrombosis and haemostasis : JTH.
[60] J. Whisstock,et al. Antithrombin: in control of coagulation. , 2004, The international journal of biochemistry & cell biology.
[61] J. Ingerslev,et al. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa , 2004, Journal of thrombosis and haemostasis : JTH.
[62] Maureane Hoffman,et al. Remodeling the Blood Coagulation Cascade , 2003, Journal of Thrombosis and Thrombolysis.
[63] K. Pasi,et al. Haemophilias A and B , 2003, The Lancet.
[64] D. Monroe,et al. Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[65] D. Monroe,et al. Coagulation Factor Interaction with Platelets , 2002, Thrombosis and Haemostasis.
[66] M. Laposata,et al. Laboratory diagnosis of dysfibrinogenemia. , 2002, Archives of pathology & laboratory medicine.
[67] A. Giles,et al. The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C) , 2002, Thrombosis and Haemostasis.
[68] K. Mann,et al. "Normal" thrombin generation. , 1999, Blood.
[69] C. Kessler,et al. Influence of phospholipids on the assessment of factor VIII activity , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.
[70] W. Heil,et al. Influence of Time and Temperature on Coagulation Analytes in Stored Plasma , 1998, Clinical chemistry and laboratory medicine.
[71] A. Stead,et al. Properties of Optical Data from Activated Partial Thromboplastin Time and Prothrombin Time Assays , 1997, Thrombosis and Haemostasis.
[72] M. Hoffman,et al. Variability in platelet procoagulant activity in healthy volunteers. , 1996, Thrombosis research.
[73] G. Broze. Tissue factor pathway inhibitor and the current concept of blood coagulation , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[74] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[75] C. Kitchens. Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultation , 1988, American journal of hematology.
[76] C. Esmon,et al. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. , 1984, The Journal of biological chemistry.
[77] J. Griffin,et al. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. , 1984, Blood.
[78] Macfarlane Rg,et al. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .
[79] M. Seeberger,et al. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.
[80] T. Orfeo,et al. Blood coagulation dynamics in haemostasis , 2009, Hämostaseologie.
[81] H. Hemker,et al. Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.
[82] Dougald M Monroe,et al. What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[83] H. Hemker,et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B , 2005, Thrombosis and Haemostasis.
[84] M. Shima. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. , 2004, Seminars in hematology.
[85] M. Greaves,et al. Role of coagulation testing in predicting bleeding risk. , 2003, The hematology journal : the official journal of the European Haematology Association.
[86] Flora Peyvandi,et al. The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding , 2002, Thrombosis and Haemostasis.
[87] J. Jespersen,et al. A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen. , 1982, Acta haematologica.